Podcasts about american colleges

Date: August 11, 2025 Guest Skeptic: Dr. Gillian Schmitz is a board-certified Emergency Physician practicing at The Naval Medical Center in San Diego. She is also a former President of the American College of Emergency Physicians (ACEP). This SGEM Xtra is inspired by the 1992 film A League of Their Own. Unlike our previous pop culture references like Buffy […] The post SGEM Xtra: Now and Forever – A League of Their Own (Women in EM) first appeared on The Skeptics Guide to Emergency Medicine.

Routine vaginal examinations (VEs) are a standard component of intrapartum care, traditionally performed at regular intervals to monitor cervical dilation, effacement, and fetal station, which are indicators of labor progression. Yet, the American College of Obstetricians and Gynecologists states that there is insufficient evidence to recommend a specific frequency for cervical examinations during labor, and examinations should be performed as clinically indicated. Now, a recently published RCT form AJOG MFM is adding additional credence to that. Can we space out clinical exams in otherwise “low-risk” laboring women to 8 hours? Listen in for details. 1. AJOG MFM: (08/18/25) Routine Vaginal Examination Scheduled At 8 vs 4 Hours In Multiparous Women In Early Spontaneous Labour: A Randomised Controlled Trial https://www.sciencedirect.com/science/article/abs/pii/S25899333250016122. Nashreen CM, Hamdan M, Hong J, et al.Routine Vaginal Examination to Assess Labor Progress at 8 Compared to 4 h After Early Amniotomy Following Foley Balloon Ripening in the Labor Induction of Nulliparas: A Randomized Trial. Acta Obstetricia Et Gynecologica Scandinavica. 2024;103(12):2475-2484. doi:10.1111/aogs.14975.3. First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8. Obstetrics and Gynecology. 2024;143(1):144-162. doi:10.1097/AOG.0000000000005447.4. Moncrieff G, Gyte GM, Dahlen HG, et al. Routine Vaginal Examinations Compared to Other Methods for Assessing Progress of Labour to Improve Outcomes for Women and Babies at Term. The Cochrane Database of Systematic Reviews. 2022;3:CD010088. doi:10.1002/14651858.CD010088.pub3.5. Gluck, O., et al. (2020). The correlation between the number of vaginal examinations during active labor and febrile morbidity, a retrospective cohort study. [BMC Pregnancy and Childbirth]6. Pan, WL., Chen, LL. & Gau, ML. Accuracy of non-invasive methods for assessing the progress of labor in the first stage: a systematic review and meta-analysis. BMC Pregnancy Childbirth 22, 608 (2022). https://doi.org/10.1186/s12884-022-04938-y

Send us a textDr. Jill Simons, a Minnesota board-certified pediatrician and Executive Director of the American College of Pediatricians, speaks with Liz Collin on her podcast about the dangers of so-called “gender-affirming care' for children—and how none of it reduces mental health problems.Donate to Alpha News - https://alphanews.revv.co/donate-todayAlpha News Links - https://linktr.ee/AlphaNewsLiz Collin Reports - https://alphanews.buzzsprout.com/Support the show

One of the things I am not particularly proud of is the fact that I don't enjoy reading books. I like to write, but when it comes to reading, I prefer shorter narratives. However, I love to celebrate authors and I'm excited that there has been a renewed interest in physical books. My guest this week is Michelle Haring, owner of Cupboard Maker Books in Enola, PA. Michelle and I talk about the increased interest in physical books that got a boost during Covid; we talk about the business of books, the fact that visitors to Cupboard Maker Books can also rescue a cat; and we chat about Michelle's life before owning the bookstore. Learn more about Cupboard Maker Books here.Thank you to my sponsors Healthy Lifestyle Management and Reinvented Threads for supporting the content of this podcast. Healthy Lifestyle Management offers services by Lisa Rigau, who is a nurse, plant predominant nutritionist and  health and well being educator as a Lifestyle Medicine professional and diplomate of the American College of Lifestyle Medicine and a Certified Mindfulness Based Stress Reduction teacher from Brown University. Learn about services offered by Lisa, like the upcoming Mindfulness Based Stress Reduction Course and how you can register, at the website.Reinvented Threads with Gabby Lynn is a business dedicated to sustainability. Gabby is incredibly creative, using existing fabrics to make unique, one-of-a-kind eco-friendly fashion accessories like handbags, hats, scarves and more. Visit Reinvented Threads here to shop online and see where you can meet Gabby in person on August 30 in the Poconos. If you would like to support this podcast, reach out to Jeannine.Luby@gmail.com to learn about podcast sponsorship packages. You can also show your support by subscribing and sharing the podcast with everyone you know. Follow Funny Wine Girl Jeannine on Facebook and Instagram.I appreciate you from the bottom of my heart and the bottom of my wine glass.

In this episode of the ACRO Podcast CURiE Conversations edition, Dr. Jessica Schuster speaks with author Dr. Leslie Chang about her published article, "Advancing Professionalism Through a Patient Safety and Quality Improvement Workshop in Radiation Oncology." Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/372473-advancing-professionalism-through-a-patient-safety-and-quality-improvement-workshop-in-radiation-oncology#!/

An Honest Account of Abortion - "Since Before Roe v. Wade: An Abortion Provider's Memoir" by Steven H. Eisinger, MD, FACOGSince Before Roe v. Wade was written with clarity, humor, and passion. This memoir presents an accurate picture of abortion to the public, including the medical and psychological realities for patients and providers, and fearlessly addresses the complex issues surrounding abortion. Numerous patient stories are presented to illustrate the many facets of abortion. Other aspects of pregnancy and childbirth, contraception, and gynecologic conditions and how they relate to abortion are discussed as well. These accounts explain technical issues to the public with the aid of vivid illustrations. Dr. Eisinger envisions his work becoming a useful source of information. In our current overheated national discussion about abortion, we need an accurate, compassionate, honest account of abortion-this is it!Steven H. Eisinger, MD, FACOG attended college at the University of Chicago, medical school at the University of Michigan, and residency in Ob Gyn at the University of Wisconsin. He then served as a Major in the Army for two years, delivering babies and doing abortions! Then, Dr. Eisinger accepted a position as an Assistant Professor at the University of Rochester (NY) Medical School in 1977, teaching Ob Gyn to resident physicians.Dr. Eisinger remained in Rochester for his entire career teaching, practicing, and conducting research, eventually retiring as Professor Emeritus in 2022. Throughout his career, Dr. Eisinger has dedicated himself to three main pursuits: providing obstetric and gynecologic care for underserved women, educating young doctors, and championing reproductive freedom, including abortion. Dr. Eisinger has performed abortions all his professional life, beginning in 1971, Since Before Roe v. Wade.Dr. Eisinger spoke at the 2024 NOW rally in Rochester, NY, to advocate for the continued availability of mifepristone, the abortion pill. He was an author of and was responsible for designing safety protocols for a nationwide scientific study on mifepristone. The study persuaded the FDA to approve mifepristone in 2000. Dr. Eisinger has since prescribed mifepristone for thousands of women. The abortion pill is safe and effective-he should know!He is a lifetime Fellow of the American College of Obstetricians and Gynecologists (FACOG). His hobbies include hiking, trail maintenance, golf, mountain climbing, and dealing in rare coins. Married with two adult children, he and his wife Sue celebrated their fifty-fifth anniversary in 2024. This book is dedicated to Sue.AMAZONwww.KingPagesPress.com  https://www.facebook.com/profile.php?id=61578414656989http://www.bluefunkbroadcasting.com/root/twia/82825kpp1.mp3        

Breaking down these 600K Chinese students. 15% of our colleges are apparently built for China. The insane bravery of WW2 pilots. Honoring the fallen. Follow The Jesse Kelly Show on YouTube: https://www.youtube.com/@TheJesseKellyShowSee omnystudio.com/listener for privacy information.

It's been over two decades since the American College of Rheumatology (ACR) last released comprehensive treatment guidelines for systemic lupus erythematosus (SLE), and much has changed. In this episode, we're joined by Dr. Lisa Sammaritano to discuss the forthcoming 2025 ACR Guidelines for the Treatment of SLE. These updated recommendations reflect a significant evolution in our approach to lupus care, from the growing range of therapeutic options to a stronger emphasis on patient engagement and minimizing steroid toxicity. We'll dive into how the guidelines tailor treatment across diverse organ systems and patient populations, and what clinicians need to know to effectively incorporate these updates into their practice. 

Listen to host Kristin Yokomoto discuss various aspects of the CLA Trusts and Estates Section Executive Committee (TEXCOM) with guests Matthew McMurtrey and Ryka Farotte.  Learn about how TEXCOM monitors all California bills, some of which become law that impact our trusts and estates practice. We discuss Matt's 11-year term on TEXCOM and Ryka's 6-year term, their leadership roles, and some of the contributions they have made to the CLA Trusts and Estates Section and the community. Learn more about the focus of TEXCOM's Legislation, Estate Planning, Incapacity, Trust Administration, and Litigation Committees and how you can become involved.Our Speakers:Matthew McMurtrey is the managing partner at Sacks, Glazier, Franklin, Lodise, McMurtrey & Scheerer, LLP in Los Angeles. Matt is a Fellow of the American College of Trust and Estate Counsel, the California Lawyer's Association Trusts and Estates Section 2021-22 Chair of the Executive Committee (TEXCOM), and a former Chair of TEXCOM's Litigation Subcommittee. Ryka Farotte is a research attorney in the Probate Department of the Los Angeles Superior Court. He is currently a member of the Executive Committee of the California Lawyer Association's Trusts and Estates Section (TEXCOM) where he serves as Chair of the Incapacity Subcommittee.  Thank you for listening to Trust Me!Trust Me is Produced by Foley Marra StudiosEdited by Cat Hammons and Todd Gajdusek

In this special episode on Strategies for Staying Full and Satisfied, our host, Dr. Neil Skolnik will moderate a discussion with Lily Correa, registered dietitian about communicating strategies for staying full and satisfied. This special edition of Diabetes Core Update is sponsored by Avocados - Love One Today ®.    For more information, as well as diabetes-friendly mean plans and a free downloadable toolkit just go to:http://loveonetoday.com/SatisfiedEating Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Lilian (Lily) M. Correa, Lily Correa is a registered dietitian and diplomate of the American College of Lifestyle Medicine   Resources and References:   Henning, Susanne M. et al. Hass Avocado Inclusion in a Weight-Loss Diet Supported Weight Loss and Altered Gut Microbiota: A 12-Week Randomized, Parallel-Controlled Trial. Current Developments in Nutrition 2019, Volume 3, Issue 8, ISSN 2475-2991. https://doi.org/10.1093/cdn/nzz068.   Khan, Naiman A. et al. Avocado Consumption, Abdominal Adiposity, and Oral Glucose Tolerance Among Persons with Overweight and Obesity. The Journal of Nutrition 2021, Volume 151, Issue 9p2513-2521. https://doi.org/10.1093/jn/nxab187.   Lichtenstein, Alice H. et al. Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial. Journal of the American Heart Association 2022, Volume 11, Number 14. https://doi.org/10.1161/JAHA.122.02565.   Pacheco, Lorena S. et al. Effects of Different Allotments of Avocados on the Nutritional Status of Families: A Cluster Randomized Controlled Trial. Nutrients 2021, 13(11), 4021. https://doi.org/10.3390/nu13114021.   Senn, MacKenzie K. et al. Associations between avocado intake and measures of glucose and insulin homeostasis in Hispanic individuals with and without type 2 diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Nutrition, Metabolism and Cardiovascular Diseases 2023, Volume 33, Issue 12, 2428 – 2439. https://doi.org/10.1016/j.numecd.2023.08.002.   Wood, Alexis C. et al. Associations between Metabolomic Biomarkers of Avocado Intake and Glycemia in the Multi-Ethnic Study of Atherosclerosis. The Journal of Nutrition 2023, Volume 153, Issue 10, 2797 – 2807. https://doi.org/10.1016/j.tjnut.2023.07.013.   For more resources, research and recipes visit LoveOneToday.com/healthprofessionals.

Diverticulosis and diverticulitis sound alike but are very different conditions—and knowing the difference is key to protecting your digestive health. In this episode, host Jacqueline Gaulin welcomes Dr. Lisa Strate, Professor and Chief of Gastroenterology and Hepatology at the University of Wisconsin, and one of the nation's leading experts in diverticular disease. Together, they clear up common questions and misconceptions about diverticulosis and diverticulitis, including: What causes these conditions and who is most at risk The symptoms and warning signs patients should watch for Whether it's possible to have one without the other How diet and lifestyle affect treatment and prevention This episode is produced in collaboration with the American College of Gastroenterology's Patient Care Committee.  

Explore estate planning that goes beyond money—trusts, family well-being, and legacy strategies to help future generations flourish. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

In our latest podcast, Dr. Schmidt talks with Mitch Gardiner, DMD, FAGD, focused on dental malpractice and the role of expert witnesses in civil court cases, with discussions about the qualifications and objectivity required of dental experts. The conversation covered key elements needed to prove negligence in dental cases, including standards of care and proper documentation of patient interactions and treatment plans. Dr. Gardiner provided advice for young dentists on maintaining high standards of care through continuous education and proper record-keeping. Dr. Gardiner is a full-time general dentist practicing in a multi-specialty office. A 1977 graduate of The University of Medicine and Dentistry of New Jersey, Dr. Gardiner served for three years as a dental officer in the Navy. He is a clinical instructor on the teaching faculty of the Rutgers School of Dental Medicine in the Department of Restorative Dentistry-Fixed Prosthodontics. He has over 25 years of experience in reviewing dental malpractice cases as an expert witness. Dr. Gardiner lectures and presents programs on issues of dental malpractice throughout the United States. He holds fellowships in the Academy of General Dentistry, American College of Dentists and International College of Dentists.

A silent danger lurks within the descending thoracic aorta. While most Type B aortic dissections are managed medically, up to half of these patients will either require life-saving surgery or die within just five years. So how do we separate those who will quietly recover from those on the edge of catastrophe? How do we protect the spinal cord, bowel, and limbs from the devastating consequences of malperfusion? Join the University of Michigan Department of Vascular Surgery as they tackle the high-stakes decisions behind managing this unpredictable disease—where timing is critical, interventions are evolving, and lives hang in the balance. Hosted by the University of Michigan Department of Vascular Surgery: ·       Robert Beaulieu, Program Director ·       Frank Davis, Assistant Professor of Surgery ·       Luciano Delbono, PGY-5 House Officer ·       Andrew Huang, PGY-4 House Officer ·       Carolyn Judge, PGY-2 House Officer Learning Objectives: 1.         Discuss general approach to diagnosis and management of TBAD. 2.         Identifying high-risk features in uncomplicated TBAD and understanding their role in determining the need for surgical management. 3.         Review endovascular techniques for managing malperfusion of the limbs, viscera, and spinal cord and discuss associated decision making. References:  Authors/Task Force Members, Czerny, M., Grabenwöger, M., Berger, T., Aboyans, V., Della Corte, A., Chen, E. P., Desai, N. D., Dumfarth, J., Elefteriades, J. A., Etz, C. D., Kim, K. M., Kreibich, M., Lescan, M., Di Marco, L., Martens, A., Mestres, C. A., Milojevic, M., Nienaber, C. A., … Hughes, G. C. (2024). EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ. The Annals of Thoracic Surgery, 118(1), 5–115. https://doi.org/10.1016/j.athoracsur.2024.01.021 de Kort, J. F., Hasami, N. A., Been, M., Grassi, V., Lomazzi, C., Heijmen, R. H., Hazenberg, C. E. V. B., van Herwaarden, J. A., & Trimarchi, S. (2025). Trends and Updates in the Management and Outcomes of Acute Uncomplicated Type B Aortic Dissection. Annals of Vascular Surgery, S0890-5096(25)00004-4. https://doi.org/10.1016/j.avsg.2024.12.060 Eidt, J. F., & Vasquez, J. (2023). Changing Management of Type B Aortic Dissections. Methodist DeBakey Cardiovascular Journal, 19(2), 59–69. https://doi.org/10.14797/mdcvj.1171 Lombardi, J. V., Hughes, G. C., Appoo, J. J., Bavaria, J. E., Beck, A. W., Cambria, R. P., Charlton-Ouw, K., Eslami, M. H., Kim, K. M., Leshnower, B. G., Maldonado, T., Reece, T. B., & Wang, G. J. (2020). Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. Journal of Vascular Surgery, 71(3), 723–747. https://doi.org/10.1016/j.jvs.2019.11.013 MacGillivray, T. E., Gleason, T. G., Patel, H. J., Aldea, G. S., Bavaria, J. E., Beaver, T. M., Chen, E. P., Czerny, M., Estrera, A. L., Firestone, S., Fischbein, M. P., Hughes, G. C., Hui, D. S., Kissoon, K., Lawton, J. S., Pacini, D., Reece, T. B., Roselli, E. E., & Stulak, J. (2022). The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection. The Annals of Thoracic Surgery, 113(4), 1073–1092. https://doi.org/10.1016/j.athoracsur.2021.11.002 Papatheodorou, N., Tsilimparis, N., Peterss, S., Khangholi, D., Konstantinou, N., Pichlmaier, M., & Stana, J. (2025). Pre-Emptive Endovascular Repair for Uncomplicated Type B Dissection—Is This an Option? Annals of Vascular Surgery, S0890-5096(25)00007-X. https://doi.org/10.1016/j.avsg.2025.01.003 Trimarchi, S., Gleason, T. G., Brinster, D. R., Bismuth, J., Bossone, E., Sundt, T. M., Montgomery, D. G., Pai, C.-W., Bissacco, D., de Beaufort, H. W. L., Bavaria, J. E., Mussa, F., Bekeredjian, R., Schermerhorn, M., Pacini, D., Myrmel, T., Ouzounian, M., Korach, A., Chen, E. P., … Patel, H. J. (2023). Editor's Choice - Trends in Management and Outcomes of Type B Aortic Dissection: A Report From the International Registry of Aortic Dissection. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery, 66(6), 775–782. https://doi.org/10.1016/j.ejvs.2023.05.015 Writing Committee Members, Isselbacher, E. M., Preventza, O., Hamilton Black Iii, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., Collins, T. J., DeAnda, A., Fanola, C. L., Girardi, L. N., Hicks, C. W., Hui, D. S., Jones, W. S., Kalahasti, V., … Woo, Y. J. (2022). 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 80(24), e223–e393. https://doi.org/10.1016/j.jacc.2022.08.004 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Contributor: Taylor Lynch, MD Educational Pearls: What is atrial fibrillation with rapid ventricular response (AFib with RVR) and how does it differ from atrial fibrillation (AFib)? AFib is an abnormal heart rhythm in which the heart has disorganized atrial electrical activity. This causes the atria to quiver with only select signals being conducted through the Atrioventricular (AV) Node to reach the ventricles and result in ventricular contraction. Often described as “irregularly irregular”, a patient's EKG will present with no discernible P-waves, and irregular R-R intervals. AFib with RVR is distinguished from AFib when the patient's ventricular rate is greater than 100-110 beats per minute in AFib with RVR. What is the treatment for AFib with RVR? Diltiazem is considered one of the first line therapeutic agents in the treatment of AFib with RVR. Diltiazem inhibits L-Type calcium channels in the AV Node, reducing the amount of signals conducted to the ventricles, thus reducing the ventricular rate. Why pretreat patients receiving Diltiazem for AFib with RVR with calcium? While diltiazem inhibits cardiac calcium channels, it may also cause peripheral vasodilation, resulting in diltiazem-induced hypotension. A recent study found that this hypotension can be blunted by pretreating with 1-2g IV Calcium Chloride (IV Calcium Gluconate can be used in the ED). Calcium is thought to peripherally stabilize the vascular smooth muscle, preventing vasodilation without impacting the desired calcium channel blocker action at the AV node. Key takeaways? In combination with slower pushes of diltiazem for patients in AFib with RVR (AFib with ventricular rate >100-110 bpm) with borderline low blood pressures, 1-2 g of IV Calcium Gluconate can combat diltiazem induced hypotension peripherally without negating the cardiac effect of diltiazem to reduce the heart rate.  References 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1-e156. doi:10.1161/CIR.0000000000001193 Az A, Sogut O, Dogan Y, et al. Reducing diltiazem-related hypotension in atrial fibrillation: Role of pretreatment intravenous calcium. Am J Emerg Med. 2025;88:23-28. doi:10.1016/j.ajem.2024.11.033 Summarized by Dan Orbidan, OMS2 | Edited by Dan Orbidan and Jorge Chalit, OMS4 Get your tickets to Tox Talks Event, Sept 11, 2025: https://emergencymedicalminute.org/events-2/ Donate: https://emergencymedicalminute.org/donate/  

For this episode join hosts John, Andy, and Tanner as they sit down with fitness coach Paul Clingan. Listen as we discuss how you can change your thoughts and actions about being healthier by nerding out a bit. Don't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org to learn more, and sign up for an upcoming CME event!

Dr. Mike Pistiner is not just an allergist and immunologist, he's also an allergy dad and fierce patient advocate. In this episode, Dr. Mike breaks down what allergies are, typical signs and symptoms and how they're treated. Have you been curious about when is the right time to use epinephrine? Then this episode is for YOU! Tune in today!Michael Pistiner, MD, MMSc is Director of Food Allergy Advocacy, Education and Prevention for the MassGeneral Hospital for Children, Food Allergy Center. He has a special interest in food allergy and anaphylaxis education and advocacy, infant food allergy management,  healthcare provider education, facilitating collaborations between the medical home and school health, and maintaining quality of life in children (and their families) with food allergies.  Dr. Mike is author of "Everyday Cool With Food Allergies", co-author of the "Living Confidently With Food Allergy" handbook, and co-founder and content creator of AllergyHome.org.Dr. Pistiner is a fellow in the American Academy of Pediatrics (AAP), where he is a member of the Section on Allergy and Immunology Executive Committee, Council on School Health and the Massachusetts Chapter of the AAP. He is also a member of the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma and Immunology.Additionally, he serves on the medical advisory board of Asthma & Allergy Foundation of America, New England Chapter and is a voluntary consultant for the Massachusetts Department of Public Health School Health Service Unit.To learn more about the Food Allergy Management Bootcamp at MassGeneral visit: https://www.massgeneral.org/children/food-allergies/food-allergy-management-boot-campTo learn more about the FAMP-It resource visit: https://famp-it.org/

(0:00) Intro(1:27) About the podcast sponsor: The American College of Governance Counsel(2:13) Start of interview(2:51) Jonathan's origin story(4:23) His Journey into Governance, initially via accounting with PwC and later with Lazard.(6:17) Types of Governance Structures(7:51) About his firm Current Capital Partners (M&A advisory, corporate management services, and PE investing).(8:31) The Inspiration Behind his book On Boards: The Modern Playbook for Corporate Governance.(10:44) Interviews that Shaped the Narrative. His standout: Admiral Michael Mullen.(13:04) Target Audience for the Book(14:48) The importance of "boards [with a roster of] best athletes, not experts in a narrow area."(17:04) His personal journey into boardrooms(19:56) Experience as an Expert Witness (21:41) Evolution of Delaware's Corporate Law. *Reference to Moelis case and Tesla's Elon Musk CEO compensation case. (24:40) AI's Impact on the Boardroom. "[I]t is critical to remember that directors oversee, but management runs the company day to day."(29:50) Navigating Geopolitical Challenges(32:01) The Rise of Shareholder Activism(34:29) Insights on Corporate Restructuring *Reference to E38 on the rise of bankruptcy directors with Jared Ellias (now at HLS)(38:33) Separation of Chair and CEO is preferable(39:00) "I think term-limits are a cop-out" there should be annual individual director evaluations.(39:43) The Need for Corporate Director Licenses.(41:36) Books that have greatly influenced his life:On a Clear Day You Can See General Motors, by Patrick J. Wright (1979)The Right Stuff, by Tom Wolfe (1979)The House of Morgan, by Ron Chernow (1990)(42:30) His mentors(43:18) Quotes that he thinks of often or lives his life by: "You can't get a hit if you don't swing the bat" "I'm dumb enough to make a decision" "It's all about tomorrow" "Have fun, life is too short"(44:24) An unusual habit or an absurd thing that he loves.(45:31) The living person he most admires: the Pope and Lebron James.Jonathan Foster is an experienced corporate director, investment banker, and expert witness in corporate litigation, and the author of the new book On Boards: The Modern Playbook for Corporate Governance. He has served on more than 50 boards, including Fortune 500 companies, private companies and companies involved in restructurings. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

In this JCO Article Insights episode, Dr. Joseph Matthew interviews authors Dr. Yang Zhang and Dr. Haiquan Chen about their recently published JCO article, "Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma" TRANSCRIPT Joseph Mathew: Welcome to the Journal of Clinical Oncology Article Insights episode for the August issue of the JCO. This is Joseph Mathew, editorial fellow for JCO, and today, it is my pleasure to have with us Dr. Haiquan Chen and Dr. Yang Zhang, authors of the recently published manuscript, "Phase 3 Study of Mediastinal Lymph Node Dissection for Ground-Glass Opacity-Dominant Lung Adenocarcinoma," which we will be discussing today. Dr. Chen is the Director of the Institute of Thoracic Oncology at Fudan University and the Chief of Thoracic Surgery at Fudan University Shanghai Cancer Center, where he is also the Head of Thoracic Oncology MDT and the Director of the Lung Cancer Center. Dr. Chen is a surgeon-scientist and a pioneer in developing individualized surgical strategies for early-stage non-small cell lung cancer. Dr. Zhang is a surgical oncologist and a member of the team which Dr. Chen leads at the Fudan University Shanghai Cancer Center. Welcome Dr. Chen and Dr. Zhang. Thank you very much for accepting our invitation and joining us today as part of this podcast episode. To summarize the salient points, this study presented the interim analysis of a multi-center, open-label, non-inferiority, randomized controlled trial investigating the necessity of systematic mediastinal lymph node dissection at the time of segmentectomy or lobectomy in patients with clinical stage T1N0M0 ground-glass opacity-dominant invasive lung adenocarcinoma, as defined by a consolidation-to-tumor ratio of 0.5 or less on thin-section computed tomography and a maximum tumor diameter of 3 cm or less. Eligible participants with intraoperatively confirmed invasive adenocarcinoma on frozen section analysis were randomized to either the systematic mediastinal lymph node dissection arm or to no mediastinal lymph node dissection. In the latter experimental group, mediastinal lymph nodes comprising the N2 nodal stations were not dissected, and the hilar nodes were variably addressed at the discretion of the operating surgeon. The primary endpoint of the trial was disease-free survival at 3 years. Secondary endpoints included perioperative outcomes, the status of lymph node metastasis in the systemic lymph node dissection arm, and 3-year overall survival. Before the trial reached its accrual target, a pre-planned interim safety analysis set for the time point when enrollment reached 300 patients was performed. It was noted that while none of the patients in either arm had nodal metastasis on postoperative pathological evaluation, lymph node dissection-related intraoperative and postoperative complications were more commonly observed in the systematic lymph node dissection arm, including one life-threatening episode of massive bleeding. Since this met the predefined criteria for trial termination, and in accordance with the principle of non-maleficence, further recruitment was stopped and the trial terminated. Although the 3-year disease-free survival and the overall survival for the enrolled patients were comparable, operative outcomes, including the duration of surgery, blood loss, chest tube duration, length of postoperative stay, and the rate of clinically significant complications, were significantly lower in the experimental arm compared with the systematic lymph node dissection group. The authors concluded that for well-selected patients, mediastinal nodal dissection could be omitted without adversely affecting oncological outcomes, representing a significant shift in current surgical practice, given that guidelines the world over recommend systematic lymph node dissection or sampling for all invasive lung cancers. In summary, this study addressed a clinically relevant question with regard to the extent of nodal dissection, especially in the light of recent evidence recommending less extensive parenchymal dissections for early-stage non-small cell lung cancer, with the findings suggesting that invasive lung adenocarcinoma associated with ground-glass opacities of consolidation-to-tumor ratio up to 0.5 was an excellent predictor of tumor biology, and in clinical T1N0M0 lesions, a reliable predictor of negative mediastinal lymph node involvement. So Dr. Chen and Dr. Zhang, could you tell us some more about what led you to do this research and the challenges which you faced while recruiting patients for this trial? Dr. Yang Zhang: Dr. Mathew, thank you for your summary. The current clinical guidelines recommend systematic lymph node dissection or sampling for every patient with early-stage lung cancer, regardless of their lymph node status. And in our clinical practice, we observe that this procedure causes a lot of surgical complications including chylothorax and recurrent laryngeal nerve injury. Furthermore, dissecting the tumor-draining lymph nodes actually may potentially damage the body's anti-tumor immunity. So, Dr. Chen proposed the concept of selective lymph node dissection, which we aimed to dissect the metastatic lymph nodes, while at the same time we try to preserve as many uninvolved lymph nodes as possible. So previously, we have conducted a series of retrospective studies to identify reliable predictors of nodal negative status in certain mediastinal zones, and we have performed a prospective observational phase 2 clinical trial to validate that the six criteria we proposed are 100% in predicting node-negative status. And this forms the basis for our phase 3 clinical trial. Dr. Haiquan Chen: This trial is only one of the series of trials. The meaning of this trial you already said. And for a long time, from the surgeon's point of view, we considered minimally invasive surgery. It minimizes the size of the incision and minimizes the number of the holes we made. So, the true and the high-impact of minimally invasive, we make a concept of minimal dissection, that means organ-level minimally invasive. So we proposed the concept of minimally invasive 3.0, that means minimal incision, minimal dissection (that means organ-level minimal), and systemic minimally invasive. So at first, we judged from the point of minimally invasive surgery. As long as immunotherapy is widely used in the clinical practice, we know immunotherapy, that means you use drugs to stimulate and activate the lymph node site. If we dissect all the metastatic lymph nodes, cut them out, how can we restimulate that lymph node site? So, from minimally invasive trauma and second, from the functional aspect, to try to save as many uninvolved lymph nodes as possible. Joseph Mathew: Thank you, Dr. Chen. That's a very interesting concept that you alluded to even in the discussion of this paper, as to the potential role of the non-metastatic lymph nodes as immune reservoirs. So, coming back to this paper, were there any challenges which you faced while recruiting patients for this trial? Dr. Haiquan Chen: The criteria is very clear. That means invasive adenocarcinoma, that means most of the centimeter is 3.0 centimeter and also CTR ratio less than 0.5. And we can see that, you know, we did study about that. Even the invasive component of the subsolid nodule, it's bigger than the solid part. That means even the pure GGO, we can find out that there's still some invasive component. From this point of view, pure GGO and subsolid GGO, from this part of invasive carcinoma, that means it's a special clinical subtype that we, from retrospective study and also prospective study, we find out this group of patients, there are no mediastinal lymph node metastasis. So I think it's very important for this kind of group that we can avoid doing the mediastinal lymph node dissection. And we can do organ-level minimally invasive surgery. And also, we try to keep the patient's immune function as normal as possible. Dr. Yang Zhang: Well, Dr. Mathew, we believe that the biggest challenge when we are enrolling these patients is that there needs to be a paradigm shift in the mind because systematic lymph node dissection has long been the standard of care. And some patients may misunderstand. Before the enrollment, we have to give them informed consent, but if the patient hears that they may be enrolled in the no-lymph-node-dissection group, they may feel that they do not receive radical, curative-intent surgery. So we believe, as Dr. Chen has said, after the release of our results, the no-lymph-node dissection may be incorporated in the future guideline for those patients without lymph node involvement, we can just omit the lymph node dissection. Joseph Mathew: The study described two pre-planned interim points during the course of subject enrollment when the data was analyzed. So Dr. Chen and Dr. Zhang, could you please explain a little more about these two interim points of analysis that were planned and the rationale behind it? Dr. Yang Zhang: When conducting this trial, we have two concerns. One is if there is any lymph node metastasis, there may be omission of metastatic lymph nodes not dissected in the no-lymph-node-dissection group. And there is another concern is that if all these lymph nodes are uninvolved, then dissecting these lymph nodes may cause life-threatening complications. So, we set the 150 interim analysis to ensure that there is no lymph node involvement in this group. And the other early termination criteria is set because if there is no lymph node involvement found in both groups, then a severe complication which is life-threatening is unacceptable because it threatens the patient's safety. Joseph Mathew: So, although you did briefly allude to in the paper, what was the basis for selecting DFS as the primary endpoint when the objective of this trial was to assess nodal involvement in this subset of tumors? Dr. Yang Zhang: Well, previously, we have done a series of retrospective studies and one prospective phase 2 trial. And in these studies, we have identified that GGO-dominant lung adenocarcinoma, even if it's invasive, it has no lymph node involvement. So this phase 3 trial was primarily designed to compare the survival outcomes. But as the trial went on, as Dr. Chen has concerns that if the patients have no lymph node metastasis at all, it may be unfair to dissect the lymph nodes for patients enrolled in the systematic lymph node dissection group. So there is one life-threatening complication that happens due to dissecting the lymph nodes and injury to the superior vena cava, which leads to massive bleeding. It is at this point that we decided to terminate this trial for patient safety concerns. Joseph Mathew: Yeah, that's a very fair point. So you made sure that the ethical considerations were kept intact. So another point was, there was a mention in the study of the historical data from your institution suggesting a 3-year disease-free survival of 96.6% for patients with clinical T1N0M0 ground-glass opacity-dominant invasive lung adenocarcinoma. So could you please elaborate on the patterns of recurrence which you noted for this group of patients who had developed a recurrence? Dr. Haiquan Chen: Yeah, I think over 90% 3-year DFS, that's the least. From our retrospective data for this kind of group of patients, their DFS is so good. To the best of my knowledge, almost 100%. So this is very conservative, 94, 90% is very conservative. I think the trial eventually would have been positive. It's a special clinical subtype, even for invasive adenocarcinoma, their prognosis is much better than the other type of invasive adenocarcinoma. Joseph Mathew: So this question may be slightly outside the purview of this study, but in your clinical practice, would you advocate either segmentectomy or lobectomy for all patients meeting the trial criteria, that is, lesions measuring 3 cm or less with a CTR of up to 0.5? Or is there a subgroup of patients you would recommend a wedge dissection for? Dr. Haiquan Chen: I think CTR ratio is one parameter and also the location is another very important parameter. So we put it together to make a decision, the patient should do a lobectomy or segmentectomy. Even for an ongoing trial, for even the patient, invasive adenocarcinoma, we can do in the right location, even wedge, it can achieve enough negative margin in the ongoing trial to verify the comparable result for the patient, we can do the wedge dissection. So not just the CTR ratio, that's not the only parameter to make a decision on what kind of procedure we'll do. Joseph Mathew: Yeah, great point, Dr. Chen. So from my perspective, this study was a well-designed, randomized control trial based on a relevant and clinically valid research question. So what, in your opinion, are the main strong points of this study? Dr. Yang Zhang: We believe that this study represents the first randomized clinical trial published, yet, regarding the topic of selective lymph node dissection. It basically offers the highest level of evidence. We believe our results should be incorporated in the future clinical guideline. Joseph Mathew: Given the increasing incidence of these lesions, I think it was- a randomized control trial in this arena was much awaited. And the other point is that GGO-dominant lung adenocarcinomas, the specific clinical guidelines are not very clear. So I think your study brought out that lymph node dissection for these tumors which satisfy the eligibility criteria could be omitted safely. Important consideration here is that the conclusions of the trial were based on an interim analysis, and this analysis was not planned for an early assessment of the primary endpoint. In other words, the study was not adequately powered to detect a significant difference in DFS at 3 years. So Dr. Chen and Dr. Zhang, what do you perceive are the most important limitations of this study which you feel should be addressed in future research? Dr. Haiquan Chen: So the surgery now is more individualized. I think the surgery from the last two decades, from the maximum tolerable intervention to minimum effective treatment, there's a big shift. So I think that the consensus, we can preserve normal lung parenchyma as much as possible. For the lymph nodes, I think that the big shift, we should shift it to keep as many as uninvolved lymph nodes as possible. So that's very important, not just to reduce the intraoperative trauma, but also to keep the immune environment as normal as possible. Joseph Mathew: Another point was the limited long-term follow-up data to determine the actual impact of omitting lymph node dissection on local-regional disease control. So is any future follow-up planned to assess the long-term survival outcomes for the 302 patients which were enrolled in this trial? Dr. Haiquan Chen: Yeah, I think that's very important for us. This trial we terminated just because if we keep the trial going, it's unfair for the mediastinal lymph node dissection group. We tried to just stop here, and we shifted to the single-arm trial. So, 2 or 3 years, this trial and another trial, they will give our final result to demonstrate more if selective mediastinal lymph nodes have a better result than ever before. And we will support the mediastinal lymph node dissection. That's one way. And the American College just asked me, how can we put this policy into clinical practice in the United States? Because most of the patients they meet have solid tumors. So we have another trial, try to figure out how we can make sure before and intraoperative the lymph node status is negative or positive, and then we can solve that problem and put this policy into clinical practice in the Western society. Joseph Mathew: Great. So that would be something we should all be looking forward to. So, this brings me to the final point of discussion on future research in this field. Dr. Chen, you commented in the paper that future studies should focus on improving the reproducibility of CTR evaluation. What are your thoughts on this subject? Dr. Haiquan Chen: The CTR ratio, the concept from the JCOG 0201, just a concept from that prospective study, the phase 2 study, only subgroup analysis they give the concept of CTR ratio and the diameter. How can we reproduce? In our group and also I believe in Japan and in China, in Korea, and in our daily practice, I think CTR ratio is not a big issue. There are two very important things. One, you make sure the CTR ratio, not in a common CAT scan, but in a high-resolution CAT scan. So the imaging, that's the first thing. And the second, not from the single section and a two or three section, you make sure that your calculation is accurate. That's not just the single section, you make sure that you got the conclusion, the CTR ratio is the same number. We make sure that totally we, from the top to the bottom of the whole lesion, we make sure that the CTR ratio is accurate. Joseph Mathew: Thank you, Dr. Chen. I think that would involve training our radiologists also to be aware of the CTR ratio and how it should be interpreted. So another very interesting concept which you had alluded to in the discussion was the potential role of non-metastatic lymph nodes as immune reservoirs. So how do you think we could preserve these nodes and do you think sentinel node biopsies would play a role in future? Dr. Yang Zhang: Actually, Dr. Chen has also led some basic research on this topic. We are investigating the immunological role of the tumor-draining lymph nodes. And our preliminary results have already shown that the tumor-draining lymph nodes of lung cancer, especially those uninvolved lymph nodes, have a vital role in the anti-tumor immunity and also effective response to the current anti-PD-1 immunotherapy. In the future, we believe that by incorporating our clinical evidence and those findings from our basic research, we will be able to provide very strong rationale to support selective lymph node dissection. Joseph Mathew: So lastly, what are the questions that still remain to be answered and what do you perceive as the next step in this field? Dr. Haiquan Chen: I think for the lung cancer surgery, especially for the cT1N0M0, they are more individualized. We can, based on the patient, the location, the CTR ratio, we can do wedge dissection, or segmentectomy, or lobectomy. For the lymph node dissection, we can do no mediastinal lymph node dissection or selective, only to dissect the positive one, or we have to do the systemic mediastinal lymph node dissection. So we can see there are too many combinations. So in the near future, for the surgery perspective, we have it more individualized. In the future, we just try to make sure we do not cut as many as possible. We just make sure that we can avoid over-diagnosis or overtreatment or over-dissected. I think that in the near future, that goal will come true. Joseph Mathew: That's a great point, Dr. Chen. So that would be something also for the thoracic oncology community to work towards. This wraps up today's episode of JCO Article Insights. Dr. Chen and Dr. Zhang, thank you very much for taking the time to join us today in what has been a very insightful session. Dr. Haiquan Chen: Thank you. Dr. Yang Zhang: Thanks. Joseph Mathew: To our audience, thank you for listening. Please stay tuned for more interviews and articles, summaries, and be sure to leave us your comments and ratings. For more podcasts and episodes from ASCO, please visit asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

I am deeply honored to reconnect with Dr. Thomas Dayspring, who joined me in 2024 for an immensely popular five-part series. Dr. Dayspring is certified in internal medicine and clinical lipidology. He is a distinguished fellow of both the American College of Physicians and the National Lipid Association.  Today, we have the first episode in a new series of conversations with Dr. Dayspring, in which he will share more of his perspective and answer more questions from listeners. In our discussion, we review the basics about cholesterol, triglycerides, and lipoproteins, exploring the factors that contribute to the development of cardiovascular disease, the significance of ApoB and Lp(a), and the risk factors for younger women. We also dive into the limitations of traditional allopathic medicines, and Dr. Dayspring shares his views on lipids, lipid changes in menopause, specific ways to address ApoB, some of the challenges associated with statin therapy, and more.  Dr. Dayspring brings a wealth of experience and expertise to this discussion, and you are sure to find this series as invaluable as the last. IN THIS EPISODE, YOU WILL LEARN: Dr. Dayspring revisits the differences between cholesterol, triglycerides, and lipoproteins What atherosclerosis is, and why it is concerning Dr. Dayspring explains the structure and function of lipoproteins The role of ApoB in lipoprotein particles and its significance in atherosclerosis Some of the risk factors for lipid abnormalities in younger women Lipid changes that occur as women transition from perimenopause to menopause  Dr. Dayspring shares his take on statin therapy Ways to address high ApoB Dr. Dayspring's suggested goals for ApoB therapy Connect with Cynthia Thurlow   Follow on ⁠X⁠, ⁠Instagram⁠ & ⁠LinkedIn⁠ Check out Cynthia's ⁠website⁠ Submit your questions to ⁠support@cynthiathurlow.com⁠ Connect with Dr. Thomas Dayspring On⁠ X⁠ (@Drlipid) On⁠ LinkedIn⁠ ⁠Journal Article: Atherosclerosis: Non-genetic influences on lipoprotein(a) concentrations⁠  ⁠Journal of the American Heart Association: Trajectories of Blood Lipid Profiles in Midlife Women: Does Menopause Matter?⁠  

Stress isn't just “in your head”—it changes your biology. It depletes nutrients like magnesium, vitamin C, B vitamins, and zinc, and keeps your body in survival mode. Supplements can help, but they won't heal you if the root cause—stress—remains. In this episode, I talk about why stress management is as critical as nutrition, how CBT and EMDR support your healing, and why lab testing matters before wasting money on supplements.   References from this episode: Juster R-P, McEwen BS, Lupien SJ. (2020). Allostatic load and allostatic overload: Clinical implications. Frontiers in Behavioral Neuroscience. https://doi.org/10.3389/fnbeh.2020.00046  Singewald N, et al. (2004). Magnesium-deficient diet alters anxiety-related behavior in mice. Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2004.10719406  Harrison FE, May JM. (2009). Vitamin C function in the brain: New evidence links ascorbate to neurotransmitter function. Brain Research Bulletin. https://doi.org/10.1016/j.brainresbull.2009.05.018  de Oliveira IJL, et al. (2015). Effects of oral vitamin C supplementation on anxiety in students. Nutrition Journal. https://doi.org/10.1186/1475-2891-14-36  Stough C, et al. (2011). The effects of 90-day administration of a high-dose B-complex vitamin on work stress. Human Psychopharmacology. https://doi.org/10.1002/hup.1190  Singh A, et al. (1991). Effect of acute stress on plasma zinc. Biological Trace Element Research. https://doi.org/10.1007/BF02990385  Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. (2018). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2012.00117  Shaw RJ, et al. (2019). Mindfulness-based stress reduction and CBT for HPA axis habituation. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2019.104420  Chen Y-R, Hung K-W, Tsai J-C, et al. (2014). Efficacy of EMDR for PTSD: A meta-analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0103676   Explore more support: Better Than Before Breast Cancer Life Coaching Membership: https://www.thebreastcancerrecoverycoach.com/lifecoaching  Creating a Life You Love in 168 Hours a Week: https://www.thebreastcancerrecoverycoach.com/168-hours-sp    Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

This week, we are joined by David Geslak, also known as Coach Dave, a pioneer in using exercise to support individuals with autism. He's the founder of a fitness program taught in nine universities and has partnered with the American College of Sports Medicine to create the Autism Exercise Specialist Certificate. David has dedicated his career to empowering the autism community through movement.   Today, we'll discuss how exercise supports development, share strategies for daily routines, and highlight the global impact of his work. Download latest episode to learn more! Resources  Facebook - @ExerciseConnection   Twitter/X - @ExerciseConnect & @davidgeslak   Instagram - @exerciseconnection & @davidgeslak   YouTube - @exerciseconnection   ............................................................... Autism weekly is now found on all of the major listening apps including apple podcasts, stitcher, Spotify, amazon music, and more. Subscribe to be notified when we post a new podcast. Autism weekly is produced by ABS Kids. ABS Kids is proud to provide diagnostic assessments and ABA therapy to children with developmental delays like Autism Spectrum Disorder. You can learn more about ABS Kids and the Autism Weekly podcast by visiting abskids.com.

Listen to TEXCOM Members Kim McGhee, Ben Schwefel, Jadene Tamura, and Kristin Yokomoto discuss the benefits of becoming a Certified Legal Specialist and the five TEXCOM modules making up the Exam and You preparation course.  The speakers will cover examination tips and briefly describe the examination topics, including professional responsibility, estate, gift, and tax planning through the use of revocable and irrevocable trusts, trust administration, accountings, probate law, powers of attorney, advance health care directives, incapacity, elder law and abuse, conservatorships, and trust and estate litigation. The Exam and You webinars discuss the five areas listed by the State Bar of California that may be on the examination, which is scheduled for October 30, 2025. To purchase a Session or bundle of 5 Sessions of The Exam and You, click here – https://calawyers.org/trusts-and-estates/exam-and-you-estate-planning-through-administration-and-litigation/ Speakers: Kimberly R. McGhee is the principal attorney at Black & McGhee, A Professional Law Corporation. She is a Certified Elder Law Attorney by the National Elder Law Foundation, a Certified Specialist in Estate Planning, Trust & Probate Law by the State Bar of California Board of Legal Specialization, V.A. Certified Accredited Attorney, and member of the California Lawyers Association, Trusts and Estates Executive Committee (TEXCOM). She is licensed in California and Nevada. Ben Schwefel is a Partner at Murtaugh Treglia Stern & Deily LLP and is a certified specialist in Estate Planning, Trust, and Probate law by the State Bar of California. Ben's practice focuses on estate planning, trust administration, probate administration, and trust litigation. Ben is a member of the Executive Committee of the Trust and Estates Section of the California Lawyers Association (TEXCOM) and the Orange County Bar Association Trusts & Estates Section. Jadene Tamura is a shareholder and co-chair of the Trusts & Estates Dept. at Parker Milliken Clark O'Hara & Samuelian, APC. Her practice includes all aspects of trusts and estates with an emphasis on estate planning and administration. She is a Certified Specialist in Estate Planning, Trust and Probate Law by the State Bar of California, and a member of the Executive Committee of the CLA Trust and Estate Section (TEXCOM). Kristin Yokomoto is a partner at Baker & Hostetler LLP in Costa Mesa, California. She practices in the areas of estate planning for high net worth clients and trust administration. Kristin is a Legal Specialist in Estate Planning, Trust & Probate Law certified by the State Bar of California. She is a Fellow of the American College of Trust and Estate Counsel (ACTEC) and Executive Committee Member of the CLA Trust and Estate Section (TEXCOM).Thank you for listening to Trust Me!Trust Me is Produced by Foley Marra StudiosEdited by Cat Hammons and Todd Gajdusek

In this episode, we chat with Dr. Olivia Patania and Dr. Lauren Stranahan of the ACVP Student Engagement Committee. They discuss veterinary student happenings at the 2024 ACVP/ASVCP annual meeting and upcoming exciting events for the 2025 Annual Meeting in New Orleans, LA. Have you thought about volunteering for ACVP? We hear how they started and why it's important. The Doctors also discuss the best time in your career to get interested in veterinary pathology - spoiler alert - it's anytime! So grab a comfy chair and get ready for a conversation with Dr. Olivia Patania and Dr. Lauren Stanahan. ___ Links Veterinary Student Engagement - https://acvp.org/training/veterinary-student-engagement/ 2025 ACVP Pathletes Registration  2025 Annual Meeting in NOLA  Student Externship Scholarships  Season 02, Episode 04 - A Conversation with Dr. Mara Varvil Season 02, Episode 05 - A Conversation with Dr. Keith Nelson of the Student Externship Scholarship Committee ACVP Errors in Publications Portal ACVP Training Program Accreditation ___ ACVP Student Engagement's Social Media Facebook: ACVP Veterinary Student Engagement Instagram: acvp_student_engagement ____ ACVP Social Media Facebook - ACVP Meetings and Topics Instagram - americancollegevetpath X (Twitter) - @ACVP LinkedIn - AMERICAN COLLEGE OF VETERINARY PATHOLOGISTS ____ Acronyms STP = Society of Toxicologic Pathology  DTF = Davis Thompson Foundation ____ Music: Guestlist by Podington Bear, licensed under an Attribution-NonCommercial 3.0 International License.  The contents of this audio do not necessarily reflect the opinions of the American College of Veterinary Pathologists (ACVP) or the participants' affiliations. Spoken audio content and associated photos are the property of the American College of Veterinary Pathologists, 2025. 

Dr. Patrick Agnew joins me for a deep dive into paediatric podiatry and the complexities of treating connective tissue disorders like Ehlers-Danlos Syndrome. With over 30 years in practice, Dr. Agnew shares how his early mentorship under Dr. James Ganley shaped his path, and why he believes more podiatrists should embrace niche work, especially with children. “You don't need 90% of your work to be niche—15% can change your career.” Today, Dr. Agnew is on the board of the American College of Foot and Ankle Pediatrics. He continues to write, speak, and advocate for greater understanding in this often-overlooked niche. According to Patrick, pediatric podiatry is an area many practitioners fear unnecessarily; mainly because the stakes seem higher and the data is often sparse. That fear is valid. But Patrick encourages curiosity over fear. “There's no competition,” he says. In fact, many podiatrists shy away from treating children because of perceived risks, parent pressure, or financial concerns. But for Patrick, those young patients are the most rewarding part of his work. If you're looking for a speaker for an upcoming event, you can email me at tyson@podiatrylegends.com or tf@tysonfranklin.com, and we can discuss the range of topics I cover. Alternatively, you can visit my speakers page - https://www.tysonfranklin.com/speaker Don't forget to look at my UPCOMING EVENTS Do You Want A Little Business Guidance?  A podiatrist I spoke with in early 2024 earned an additional $40,000 by following my advice from a 30-minute free Zoom call.  Think about it: you have everything to gain and nothing to lose, and it's not a TRAP. I'm not out to get you; I'm here to help you.  Please follow the link below to my calendar and schedule a free 30-minute Zoom call. I guarantee that after we talk, you will have far more clarity on what is best for you, your business and your career. ONLINE CALENDAR Business Coaching I offer three coaching options: Monthly Scheduled Calls. Hourly Ad Hoc Sessions. On-Site TEAM Training Days around communication, leadership and marketing.   But let's have a chat first to see what best suits you. ONLINE CALENDAR Facebook Group: Podiatry Business Owners Club  Have you grabbed a copy of one of my books yet?  2014 – It's No Secret There's Money in Podiatry  2017 – It's No Secret There's Money in Small Business  

Dr. Jaclyn Tomsic completed her oral and maxillofacial surgery training at Detroit Medical Center, rotating through Level I trauma centers including Detroit Receiving and Henry Ford Hospitals. She earned her medical degree from Wayne State University and completed a general surgery internship and chief year in OMF surgery. She then completed a fellowship at Georgetown University Hospital and the Posnick Center for Facial Plastic Surgery, focusing on jaw reconstruction, orthognathic, and facial plastic surgery. After another year as a surgery resident at Washington Hospital Center, she completed a fellowship in facial cosmetic and TMJ surgery at Mercy Hospital in St. Louis, earning Fellowship in the American College of Surgeons. Now based in her hometown of Cleveland, Dr. Tomsic focuses on facial cosmetic surgery, trauma, and implant surgery. Outside of work, she enjoys sports, fitness, travel, and time with family and friends.

Aug. 21, 2025- Dr. Rachel Flink-Bochacki, a board certified OBGYN and legislative chair of the American College of Obstetricians & Gynecologists District II, shares concerns with legislation requiring health care providers to share information about IUDs, including pain associated with insertion, when discussing birth control with patients.

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginHow do you grow from one pharmacy to 32...and still sleep at night?That's a question unicorn pharmacy owners can answer and this week we're joined by one!In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA and Austin Murray sit down with Bill Osborn, President at Osborn Drugs and pharmacy industry veteran, for an unscripted, insightful conversation that spans decades of wisdom, wit, and work ethic.From navigating PBM reform and workforce shortages to embracing AI and technology, we jump into the "Pharmacy Time Machine" to discuss:- The evolving role of AI and automation in pharmacy- How Bill built a 32-store network rooted in local ownership- Partnership structures, buy-sell agreements, and long-term sustainability- And more!More About Our Guest: Bill Osborn is President of Osborn Drugs, Inc. and started working in the pharmacy in different capacities since the age of 13. A Miami OK native, Bill graduated from Miami High School (1978) and received his Associates degree (1980) from NEO A&M College. He obtained his Bachelor (1984) and Doctorate of Pharmacy (2003) from the University of Oklahoma.He currently serves as co-chair of Unify Rx and is on the board of AlignRx. Bill also serves on the board of directors of Surescripts, LLC, the Premier Value Alliance, and First National Bank of Miami. Bill served a 10-year term on the Oklahoma State Board of Pharmacy and is a current member of the Oklahoma Pharmacists Association and the American College of Apothecaries. Bill is a graduate of University of Oklahoma College of Pharmacy.Connect with Bill Osborn and Osborn Drugs:  Bill Osborn LinkedInProRx WebsiteOsborn Drugs WebsiteOsborn Drugs FacebookStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - PBM Reform Act and Medicare Drug Pricing Changes

In this episode, Tom Varghese, MD, FACS, is joined by Timothy Pawlik, MD, FACS, from The Ohio State University. They discuss Dr Pawlik's recent article, “Association of Discharge Against Medical Advice with Surgical Outcomes and Healthcare Cost,” in which the authors found that discharge against medical advice (DAMA) among surgical patients is associated with increased 30-day readmission, complication, fragmented care, and higher healthcare cost. DAMA patients were younger, socioeconomically vulnerable, and often had substance use or psychiatric disorders.     Disclosure Information: Drs Varghese and Pawlik have nothing to disclose.    To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.    #JACSOperativeWord 

Over 50 million Americans suffer from a range of frustrating allergy symptoms from hay fever to asthma, hives to sinusitis. Many have tried medications, visited allergists, and used various treatments, desperate to find a reliable way to alleviate their pain, but just can't seem to get the dependable relief they need. Now, one of New York's top allergists, Dr. Dean Mitchell, lifts the cloud of mystery surrounding allergies and offers a breakthrough new treatment program that will dramatically lessen their severity, if not cure them for good. In Dr. Dean Mitchell's Allergy and Asthma Solution, Mitchell clearly and comprehensively explains what allergies are, why they are so prevalent, and all of the standard treatments. He then presents a cutting edge 5-step program for reversing allergies called sublingual immunotherapy, or "allergy drops." This new treatment, widely accepted in Europe but still relatively unknown in the United States, is painless, convenient, incredibly effective, and completely safe since it works naturally through the body's immune system. Even better, it can be customized to meet specific needs, is shot-free, and can be self-administered. Dr. Dean Mitchell's Allergy and Asthma Solution is the best guide to understanding allergies and overcoming their symptoms.Dean Mitchell, MD, is the leading expert in sublingual allergy immunotherapy in the United States. He had been in practice for seven years following the conventional methods of allergy cures when he first learned of sublingual allergy immunotherapy (allergy drops) and has been one of its strongest proponents. He now runs a private practice, Ocean Allergy & Nutrition, in Manhattan. Dr. Mitchell's patients come from all over the US to receive his treatments. He is a fellow of the American College of Allergy, Asthma, and Immunology and is a member of the Joint Council of Allergy and Immunology.For ten years he was a clinical instructor of medicine at Columbia College of Physicians and Surgeons. He graduated from Brown University in 1982 and received his MD from the Sackler School of Medicine at Tel Aviv University in 1986. He lives in Long Island with his wife and two sons. When he's not busy with his patients, he enjoys playing baseball with his kids.https://www.mitchellmedicalgroup.com/about/dr-dean-mitchell/?utm_source=google&utm_medium=referral&utm_campaign=gmb_dean?utm_source=GMB&utm_medium=DeanBecome a supporter of this podcast: https://www.spreaker.com/podcast/earth-ancients--2790919/support.

Welcome to Season 14 Episode 31 of the ParentingAces Podcast! In this week's episode, Dr. Mark Kovacs is back to dive deeper into a recent social media post about the decreased fitness levels he's seeing in junior tennis players and what we can do to help our players get fit and stay injury-free.In case you're unsure as to why you should pay attention to what Mark has to say, he is a renowned performance physiologist, researcher, university professor, author, speaker and coach with an extensive background training and researching athletes at all levels. He serves the iTPA membership as its Executive Director. He formally directed the Sport Science, Strength & Conditioning and Coaching Education departments for USTA. He is a Fellow of the American College of Sports Medicine and the ITPA. He has published over 50 peer-reviewed scientific articles and abstracts in top journals including the British Journal of Sports Medicine, Sports Medicine, Sports Health, International Journal of Sport Physiology and Performance, Strength & Conditioning Journal, Journal of Sports Science and Medicine among many others. He has presented workshops and keynote addresses on four continents and well over 100 presentations. Along with his academic and scientific background Dr. Kovacs is also a coach and former professional athlete. He was an All-American and NCAA doubles champion in tennis at Auburn University. After playing professionally, he completed his graduate work at Auburn University and earned his Ph.D. in Exercise Physiology from The University of Alabama. Dr. Kovacs is a Certified Strength and Conditioning Specialist through the National Strength and Conditioning Association, a certified Health/Fitness Specialist through the American College of Sports Medicine, a United States Track and Field Level II Sprints Coach and Certified Tennis Coach. This man has the bona fides!You'll hear Mark discuss the Gatorade Sweat Patch as an easy tool to measure sweat level. You can get more information and order them through the Gatorade website at https://www.gatorade.com/equipment/gx-sweat-patch/gx-sweat-patch-00052000048520. Mark and I also discuss his recent article on combating jet lag which you can find here: Click HereTo reach out to Mark directly, email him at mark@kovacsinstitute.com. You can also follow him on Instagram at https://instagram.com/drmarkkovacs. To find our podcast on periodization, go to https://parentingaces.com/podcasts/what-is-periodization-how-do-we-use-it-with-dr-mark-kovacs/.As always, I am available for one-to-one consults to work with you as you find your way through the college recruiting process. You can purchase and book online through our website at ⁠⁠⁠⁠⁠⁠⁠⁠https://parentingaces.com/shop/category/consult-with-lisa-stone/⁠⁠⁠⁠⁠⁠⁠⁠.If you're so inclined, please share this – and all our episodes! – with your fellow tennis players, parents, and coaches. You can subscribe to the podcast on Apple Podcasts or via your favorite podcast app. Please be sure to check out our logo'd merch as well as our a la carte personal consultations in our ⁠⁠⁠online shop⁠⁠⁠.CREDITSIntro & Outro Music: Morgan Stone aka STØNEAudio & Video Editing: Lisa Stone

Food Poisoning: Causes and Prevention Did you know you're not supposed to rinse meat for fear of the viral and bacterial splatter? Washing chicken in the sink can spew droplets containing culturable levels of pathogens throughout the kitchen. And why do contaminated poultry products cause the most foodborne deaths? Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #plantbasedbriefing #wfpb #foodpoisoning #ecoli #Salmonella #campylobacter #fecalsoup ============================ Original post: https://nutritionfacts.org/video/food-poisoning-causes-and-prevention/    ========================== Related Episodes Use Search Field where you listen (or at PlantBasedBriefing.com/episodes) and enter related terms ============================ Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Age, How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity. ============================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

Ênio Macedo e Joanne Alves convidam Eduarda Guedes e Mariana Tourinho, R2 CM do HCMFMUSP, para discutir sobre 7 armadilhas na Doença arterial periférica (DAP), antiga DAOP.1.⁠ ⁠Não reconhecer manifestações clínicas iniciais 2.⁠ ⁠Valorizar somente o exame físico e não realizar o ITB 3.⁠ ⁠Solicitar exame de imagem no diagnóstico4.⁠ ⁠Focar apenas no tratamento farmacológico5.⁠ ⁠Não usar os tratamentos farmacológicos disponíveis6.⁠ Não reconhecer o momento de indicar revascularização7.⁠ ⁠Não reconhecer isquemia de membro agudaReferências: 1. https://www.tadeclinicagem.com.br/guia/324/doenca-arterial-obstrutiva-periferica-diretriz-ahaacc-2024/2. Gornik, Heather L et al. “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Circulation vol. 149,24 (2024): e1313-e1410. doi:10.1161/CIR.00000000000012513. Khan, Nadia A et al. “Does the clinical examination predict lower extremity peripheral arterial disease?.” JAMA vol. 295,5 (2006): 536-46. doi:10.1001/jama.295.5.5364. Londero, Louise S et al. “Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease.” Journal of vascular surgery vol. 63,5 (2016): 1305-10. doi:10.1016/j.jvs.2015.11.044

Nearly half of Americans have high blood pressure — and the guidelines for managing it just changed. Dr. Sanjay Gupta explains the new rules, including surprising advice on alcohol. Plus, he answers a listener's follow-up: does the recommended daily dose of “morning sunlight” change when it's cloudy, rainy, or even snowing? New blood pressure guidelines recommend an earlier start to treatment and skipping alcohol, CNN, August 14, 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, The American College of Cardiology/ American Heart Association, August 14, 2025 Our show is produced by Eryn Mathewson, Jennifer Lai, Grace Walker, Lori Galaretta, Jesse Remedios, Sofia Sanchez, Kyra Dahring, and Madeleine Thompson. Medical Writer: Andrea Kane Showrunner: Amanda Sealy Senior Producer: Dan Bloom Technical Director: Dan Dzula Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join Elevated GP: www.theelevatedgp.com Net32.com  Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram His interdisciplinary approach to dentistry is founded in both empirical research and clinical experience. He attended the University of Washington for both his undergraduate and graduate studies where he received his D.D.S. degree in 1995 and an M.S.D. and certificate in Prosthodontics in 1998. For his entire career, Dr. Kinzer has been committed to furthering the art and science of dental education. His unique ability to impart complex clinical processes in a logical, systematic and clear methodology differentiates him from other Prosthodontists and makes him a highly regarded educator nationally and internationally. He is a full-time teaching faculty at Spear Education in Scottsdale, AZ. where he is also resides as the Faculty Chairman and Director of Curriculum and Campus Education. Dr. Kinzer is an Affiliate Assistant Professor in the Graduate Prosthodontics Department at the University of Washington School of Dentistry and an Adjunct Faculty at Arizona School of Dentistry and Oral Health. Dr. Kinzer is a member of many professional organizations including the American Academy of Restorative Dentistry and the American Academy of Esthetic Dentistry, of which he is currently the sitting President. He serves on the editorial review board for several recognized dental publications and has written numerous articles and chapters for dental publication. He has been honored with the American College of Prosthodontics Achievement Award and in 2018, he received the Saul Schluger Memorial Award for Excellence in Diagnosis and Treatment Planning from the Seattle Study Club. In 2022 he was inducted into the World's Top 100 Doctors as part of the Interdisciplinary Cohort. In his free time, Gregg cherishes spending time his wife Jill and their 6 children. He enjoys anything that he can do outside: golfing, hiking, running, skiing, and biking, in addition to a nice glass of wine.

In episode #389 of The Hormone Puzzle Podcast, our guest Dr. Roxanne Pero, talks about Toxins and Infertility. More about Dr. Roxanne: Dr. Roxanne Pero is a triple-board certified OB/Gyn with expertise in Obstetrics, Gynecology, Infertility, Functional Medicine, and Lifestyle Medicine. She earned her M.D. from Louisiana State University Health Sciences Center and completed her residency at UT Southwestern/Parkland Hospital in Dallas. After 12 years in private practice, guiding women through complex and high-risk pregnancies, she transitioned into holistic care. For the past three years, she has focused on root-cause healing and is board certified through the Institute for Functional Medicine and a Fellow of the American College of Lifestyle Medicine. Dr. Pero now practices at Alive & Well Dallas, where she helps patients address chronic conditions through integrative, lifestyle-driven protocols, combining conventional and functional approaches for whole-person healing. Thank you for listening! This episode is made possible by Puzzle Brew's Fertility Tea: https://hormonepuzzlesociety.com/fertility-tea Follow Dr. Roxanne on Instagram: @‌drroxannepero Follow Dr. Kela on Instagram: @‌kela_healthcoach Get your FREE Fertility Meal Plan: https://hormonepuzzlesociety.com/ FTC Affiliate Disclaimer: The disclosure that follows is intended to fully comply with the Federal Trade Commission's policy of the United States that requires to be transparent about any and all affiliate relations the Company may have on this show. You should assume that some of the product mentions and discount codes given are "affiliate links", a link with a special tracking code This means that if you use one of these codes and purchase the item, the Company may receive an affiliate commission. This is a legitimate way to monetize and pay for the operation of the Website, podcast, and operations and the Company gladly reveals its affiliate relationships to you. The price of the item is the same whether it is an affiliate link or not. Regardless, the Company only recommends products or services the Company believes will add value to its users. The Hormone Puzzle Society and Dr. Kela will receive up to 30% affiliate commission depending on the product that is sponsored on the show. For sponsorship opportunities, email HPS Media at media@hormonepuzzlesociety.com

In our journey to personal flourishing, we explore powerful life lessons—like savoring the moment, practicing gratitude, letting go of grudges, prioritizing what matters, and even taking bold risks. Packed with stories, research, and timeless wisdom, this episode will inspire you to live more fully—one moment at a time. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.

I'm a new fan! She and I have a great convo on health and wellness, Here book is valled Fabulous Health: A Simple Plan to get well and stay well. Got to amazon and other places you find books! Terri Chrisman is a board-certified nutritionist with the American College of Lifestyle Medicine, a dynamic speaker, podcaster, and author. With a Master's in Human Nutrition from Deakin University and a background in Sport and Exercise, she blends scientific research with practical guidance to empower people toward vibrant, sustainable wellness . As the founder of the Fabulous Health Show podcast and the FabulousHealth.net community, Terri shares actionable strategies for thriving—not just surviving—by reclaiming energy, preventing chronic disease, and embracing whole-food, plant-based living.

(0:00) Intro(1:31) About the podcast sponsor: The American College of Governance Counsel(2:18) Start of interview. *Reference to E36 (June 2021) for personal/professional background, and E90 (March 2023)(3:13) Celebrating 25 Years of the Weinberg Center(3:47) Uncovering John Weinberg's 1948 Thesis. Details for the Symposium at the Weinberg Center on Oct 9, 2025.(6:12) The role of boards and directors from a historical perspective. *Reference to Gilson and Gordon's article on Boards 3.0.(8:17) The contribution of the Weinbergs to corporate governance: Sydney led Goldman Sachs from 1930 to 1969,  and John led GS from 1976-1990.(14:04) The Relevance of Historical Governance Debates. *Reference to the Startup Litigation Digest.(16:53) Delaware's current corporate law challenges: charter competition with Nevada, Texas, and other states (and Fed Govt).(24:35) The Impact of Delaware's SB 21 Legislation. *Reference to a16z's statement on leaving DE (and Larry's take on it). Reference to Delaware's SB 313 partially in response to the Moelis decision (on validity of stockholder agreements).(33:10) On Delaware's DExit: "I barely see a trickle, let alone a flood."(39:27) The Future of Delaware's Corporate Landscape(44:17) Remembering Charlie Munger's Influence(45:56) Warren Buffett's contribution to governance and the future of Berkshire Hathaway(48:22) Goals for the Weinberg Center's Future(49:55) The Evolving Role of Corporate Directors. "[B]oards of directors are here to oversee, not to be experts, to ask discerning questions, to press, to query, but not to micromanage or get in the way." "Nose in, fingers out" attributed to John Nash, founder of NACD.Larry Cunningham is the Director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, and a leading scholar, author, and advisor on corporate governance and board matters.   You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

Send comments and feedbackWhat are variants of uncertain significance (VUS) in epilepsy genetic testing? How are they defined, and can those definitions change over time? Sharp Waves talks with Dr. Gemma Carvill as part of our genetic testing series.RESOURCESStandards for interpreting variants (American College of Medical Genetics)Gene ReviewsClinVarGeneMatcherGnomadClinGenILAE genetic literacy seriesEpiPred website for STXBP1 (developed by EpiMVP project - will be final by end of July)Think Genetics paper – genetic testing in South Africa projectLink to Sharp Waves episode on genetic testing in LMICs  Sharp Waves episodes are meant for informational purposes only, and not as clinical or medical advice.Let us know how we're doing: podcast@ilae.org.The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Instagram, and LinkedIn.

Kevin Barber, MD, speaks with Cynthia Matossian, MD, and Sara O'Connor, MD, MPH, about strategies to address workforce shortages and training gaps in ophthalmic care. Dr. Matossian outlines the American College of Eye Technicians and its technician training model to expand career awareness and technical competency, and Dr. O'Connor describes ACE Global's ophthalmic technician program in Honduras and a community health worker curriculum. Dr. Barber reviews distance surgical mentorship, a smartphone-to-microscope telementoring approach that supports ophthalmologists in low-resource settings as they transition to independent cataract surgery. Together, these initiatives illustrate a scalable, team-based pipeline to build capacity and reduce preventable blindness; related perspectives appear in CRST's June 2025 “Bridging the Gap” issue. Related reading: "A Workforce Solution to Expand Access to Eye Care" "Scaling Surgical Mentorship Across Borders"

Ralph devotes the entire program to challenging the “official” count of 60 thousand fatalities reported so far in the genocide Israel, aided and abetted by the United States, has perpetrated on the Palestinians in Gaza. First, Dr. Feroze Sidhwa, who volunteered twice in Gaza hospitals, presents the various studies that revise estimates into the hundreds of thousands. Then weapons expert, Professor Theodore Postol, backs that up with his knowledge of the destructive power of the weapons being used and the photographic evidence of the rubble.Dr. Feroze Sidhwa is a trauma, general, and critical care surgeon. He has volunteered twice in Gaza since 2024 and three times in Ukraine since 2022. He has published on humanitarian surgical work in the New York Times, Politico, and the Journal of the American College of Surgeons.I've made my point clear month after month that I believe the death toll is now well over 500,000. And it's important to have an accurate death toll to respect the Palestinian dead and to intensify diplomatic, political, and civic pressures from around the world (and particularly from the White House and Congress) to cease fire, to let the humanitarian trucks that are already at the border in (with food, medicine, water, hospital supplies), and to make sure that this conflict is resolved safely.Ralph NaderIt certainly seems that every single international expert on the topic does think that this is a genocidal attack, so I don't see any reason to disbelieve what they're saying. But that doesn't have to do with how many people are killed. So what I'm just trying to point out is that even if the numbers of people that we talk about here today are (like Ralph said) half a million, or whatever number of people have been killed, nobody disputes that huge numbers of mass killings have taken place. And it doesn't seem that anybody who knows what they're talking about disputes that it's genocidal at this point.Dr. Feroze SidhwaIt's been very widely understood by lots and lots of people, of a huge variety of political leanings, a huge variety of life experiences, of professions, et cetera, that this is the image that springs to mind when they go to the Gaza Strip—it's something like a gigantic concentration camp.Dr. Feroze SidhwaIf the U.S. or Israel cared at all about how many people (including, remember, this is a territory that is half children) —if we cared how many people, including children, we have starved to death, have shot dead, have blown up, et cetera, we could figure it out in two weeks and with 10 grand. The Israelis wouldn't even have to stop their assault. They could keep doing it. They could just agree to de-conflict this group of a few people. But they won't do it for obvious reasons. And I shouldn't say “they” —we won't do it for obvious reasons.Dr. Feroze SidhwaTheodore Postol is Professor of Science, Technology and National Security Policy Emeritus in the Program in Science, Technology, and Society at MIT. His expertise is in nuclear weapon systems, including submarine warfare, applications of nuclear weapons, ballistic missile defense, and ballistic missiles more generally.When you have a large building collapse, everyone is going to be dead unless they're out of the building. It's just that simple. And even when you have large buildings collapse and you have people coming in to search for people, you typically only find a few people who happen to have been lucky enough to be trapped in a cavity that's near a surface area of the rubble heap. If you're deep in the rubble heap, your chances of surviving are near zero.Professor Theodore PostolNews 8/15/25* New Bureau of Labor Statistics Consumer Price Index data shows Trump's new tariff regime has resulted in significant increases in tariff-sensitive staple consumer goods. Some startling price spikes include a 38.9% rise in the price of vegetables, 14.5% increase in the price of coffee and an 11.3% increase in the price of beef and veal. Beyond food, electricity is up 5.5%, rent and shelter is up 3.6%, and health insurance is up 4.4%. These increases are sure to be politically unpopular, as Trump campaigned on bringing down inflation and the price of groceries. The reporting of this data also raises questions about Trump's response, given his response to the recent negative BLS data reporting on new job creation.* Speaking of job creation data, while the U.S. only reported the creation of 73,000 new jobs in July, Mexico, under left-wing economic nationalist president and AMLO successor Claudia Scheinbaum, created over 1.26 million new jobs in the same month, according to Mexico News Daily. Furious about the jobs report, Trump forced out the head of the Bureau of Labor Statistics and is now seeking to install right-wing economist EJ Antoni. According to the BBC, economists have said his “economic commentary [is] rife with basic mistakes.” Antoni, kowtowing to Trump, ​​has proposed ending the monthly jobs report. Antoni would need to be confirmed by Senate Republicans, who have expressed some trepidation about his appointment, but whether that will be enough for them to stand up to Trump on this appointment seems unlikely.* In more domestic economic news, Jacobin reports corporations are experimenting with a new method of worker exploitation – so-called “stay-or-pay” contracts. According to this article, millions of employees – from nurses to pilots to fast food workers – are, often unwittingly, being “inserted into…restrictive labor covenants [which] turn employer-sponsored job training and education programs into conditional loans that must be paid back — sometimes at a premium — if employees leave before a set date.” These contracts, known as Training Repayment Agreement Provisions, or their acronym TRAPs, have become a major new battleground between corporate interests and groups fighting for labor rights, including unions and regulators. However, with Trump administration efforts to rollback even the modest labor protections promulgated under the Biden administration, the possibility of any federal intervention on behalf of workers seems remote.* In more Trump-related news, the occupation of Washington, D.C. has commenced. Trump has deployed federal agents, including officers with the Department of Homeland Security and Drug Enforcement Administration, as well as National Guard troops, to patrol the streets of the capital. Some of these deployments seem to be mostly for media spectacle; feds have been seen patrolling tourist areas like the National Mall, Union Station and Georgetown, but others have been going into District neighborhoods and harassing District residents for smoking on their own property. Moreover, while Trump has said "Our capital city has been overtaken by violent gangs and bloodthirsty criminals, roving mobs of wild youth, drugged-out maniacs and homeless people," the Justice Department has in fact announced that this year violent crime in Washington has hit a 30-year low, per NPR. Trump is restricted to a 30 day takeover of the District by law, but is seeking to extend this window through Congress.* As usual, even as Trump claims to be cracking down on crime, his administration treats corporate crime with kid gloves. Despite major news of corporate misconduct this week – including the reopening of a Boar's Head facility shut down earlier this year due to a listeria outbreak despite ongoing sanitation issues and an explosion at the Clairton Coke Works in Pittsburgh that left at least two dead and ten injured – a new Public Citizen report shows the extent of the administration's soft-on-corporate-crime approach. According to this report, “the Trump administration has already withdrawn or halted enforcement actions against 165 corporations of all types – and one in four of the corporations benefiting from halted or dropped enforcement is from the technology sector, which has spent $1.2 billion on political influence during and since the 2024 elections.”* Turning to Gaza, the Financial Times reports, “Israel has killed…prominent Al Jazeera correspondent [Anas Al-Sharif] in Gaza and four of his colleagues…in an air strike targeting them in a media tent.” This report notes the Israeli military “took credit” for the strike after “months of threats and unproven allegations that [the journalist] was the head of a Hamas cell.” The Committee to Protect Journalists called these claims an attempt to “manufacture consent for his killing.” The network called this move a “desperate attempt to silence voices in anticipation of the occupation of Gaza.” Anas Al-Sharif was a prominent journalist in the Arab world and was part of a Reuters photo team who won a Pulitzer Prize in 2024. Israel has already killed six Al Jazeera reporters in Gaza prior to this strike.* Meanwhile, in Egypt, President Abdel Fattah El-Sisi last Tuesday issued his harshest criticism of Israel thus far, accusing the nation of prosecuting “a war for starvation, genocide, and the liquidation of the Palestinian cause.” Yet, according to Drop Site News, Sisi's comments came just days before an announcement that an Israeli company will begin supplying Egypt with vast amounts of gas. This $35 billion deal between Egypt, neighbor to Israel and Palestine and the largest Arab nation, and Israeli energy company NewMed is the largest export agreement in Israel's history. This deal adds a new dimension to other comments Sisi made in those same remarks, wherein he defended Egypt against criticism for “not opening the Egyptian side of the Rafah border crossing to allow in aid.” It remains to be seen whether the genocide comments represent a new chapter of Egypt-Israel relations, or whether they are just a smokescreen to cover Egypt and Israel's increasing economic interdependence.* In Palestine news from the homefront, Semafor reports the Democratic National Committee will consider two dueling resolutions on Gaza at their meeting this month. According to Dave Weigel, one, introduced by DNC Chair Ken Martin would “[urge] a ceasefire and a return of hostages held by Hamas,” along with a reaffirmation of the increasingly far-fetched two-state solution. The other, introduced by a DNC member on the progressive flank of the party, calls for “suspension of military aid to Israel” and recognition of a Palestinian state. The latter resolution has drawn the ire of Democratic Majority for Israel, a political organization that aims to keep the Democratic Party firmly in the pro-Israel camp. DMFI's president, Brian Romick, is quoted saying that resolution would be a “gift to Republicans” and would “embolden Israel's adversaries.”* In more positive foreign affairs news, Jeremy Corbyn's new party in the United Kingdom appears to be gaining steam. A string of polls indicate the party could win the seats currently held by several high-profile Labour Party MPs, including Health Secretary Wes Streeting and now-resigned Homelessness Secretary Rushanara Ali. Most shockingly, it seems they could even win Holborn and St. Pancras, the seat currently held by Labour Party Prime Minister Keir Starmer. If this Corbynite wave does ultimately crest, it would be a stunning reversal of fortune after the Starmerite Labour Party expelled the former Labour leader in 2023.* Finally, AOL announced this week that they will end their Dial-up internet service in September, Ars Technica reports. AOL launched their Dial-up service in 1991, helping to usher in the era of widespread internet adoption. While this may seem like a natural step in terms of technological advancement, US Census data from 2022 shows that approximately 175,000 American households still connect to the Internet through dial-up services. As this article notes, “These users typically live in rural areas where broadband infrastructure doesn't exist or remains prohibitively expensive to install.” In effect, this move could leave these rural communities completely without internet, a problem compounded by the Trump administration's decision earlier this year to “abandon key elements of a $42.45bn Biden-era plan to connect rural communities to high-speed internet,” per the Guardian. It should be considered a national disgrace if both the private sector and the government leave these rural communities behind.This has been Francesco DeSantis, with In Case You Haven't Heard. Get full access to Ralph Nader Radio Hour at www.ralphnaderradiohour.com/subscribe

Today's guest is Dr. Abby Armwood, an Assistant Professor in the Department of Population Health and Pathobiology at North Carolina State University, College of Veterinary Medicine. Dr. Armwood sat down with us at the 2024 ACVP/ASVCP Annual Meeting in Seattle, WA, to tell us more about the ACVP Student Engagement Committee (SEC) and their commitment to creating fun and educational events. Hear more about Patheletes, kicking off at the 2025 Annual Meeting in New Orleans, LA, and the veterinary student mentoring program. Dr. Armwood also discusses the Pathology Training Committee and its role in enhancing the quality of pathology training programs. And, we hear about her journey in pathology–from an interest in becoming an aquatic veterinarian to expertise in all things aquatic pathology! Grab a snack and join us for a conversation with Dr. Abby Armwood.     If you want to connect with the ACVP SEC, you can find them:  Facebook - ACVP Veterinary Student Engagement Committee ___ More Information on: 2025 ACVP Annual Meeting in NOLA Maintenance of Certification More Information on the ACVP Training Program Accreditation AQUAVET(R) - Cornell University College of Veterinary Medicine ACVP Errors in Publications Portal ___ ACVP Social Media Facebook - ACVP Meetings and Topics Instagram - americancollegevetpath X (Twitter) - @ACVP LinkedIn - AMERICAN COLLEGE OF VETERINARY PATHOLOGISTS  ____ Thank you to Dr. Andrea Kerr, of the MCC Podcast Subcommittee, for editing this episode. Music: Guestlist by Podington Bear, licensed under an Attribution-NonCommercial 3.0 International License.  The contents of this audio do not necessarily reflect the opinions of the American College of Veterinary Pathologists (ACVP) or the participants' affiliations. Spoken audio content and associated photos are the property of the American College of Veterinary Pathologists, 2025. 

Breaking Barriers, Making Healthy Choices, and Embracing Survivorship Breaking Barriers, Making Healthy Choices, and Embracing Survivorship. In this episode Yonni and Heather sit down with Dr. Laurie Kirstein from Memorial Sloan Kettering Cancer Center, who made history as the first female chair of the American College of Surgeons' Commission on Cancer. We will talk about breaking glass ceilings, access to quality healthcare, pain management and the impact of smoking on women's health outcomes. Dr. Laurie Kirstein is an Attending Breast Surgeon at memorial string Cancer Center. She attended downstate medical school, Montefiore Medical Center/Albert Einstein University for residency and Massachusetts General Hospital for Breast Surgery fellowship. Prior to arriving at Memorial Sloan Kettering she was attending surgeon and Breast Fellowship Director at the Rutgers Cancer Center Institute of New Jersey. At Memorial SloanKettering she is the Surgical Site Director for their Monmouth, NJ location. She is the current Chair for the American College of Surgeon's Commission on Cancer. She is the lead for the national quality improvement project Breaking Barriers: overcoming barriers to cancer care across America. Her research interests include surgical decision for breast cancer, postoperative pain management and tobacco cessation for cancer patients. Find Yonni & Heather here https://www.herhealthcompass.com/

Lisa (Elizabeth) Joyce Freeman serves as a Senior Advisor in the School of Medicine at Stanford University. She administratively supports the Stanford Medicine Center for Improvement. The goal of the Stanford Medicine Center for Improvement is to become the best at getting better Inspiring and accelerating the delivery of consistent, excellent care across Stanford Medicine measured by performance improvement in Safety, Quality, Patient Experience, and Cost Reduction (Collectively=Value) from today's baseline and ultimately developing a reputation as a national leader, to which others look for inspiration and as an educational resource. From 2001 through 2016, she was the Chief Executive Officer of the VA Palo Alto Health Care System (VAPAHCS). VAPAHCS is a $900M, 800 - bed federal health care system with three inpatient divisions and seven outpatient clinics serving 90,000 Veterans in 10 counties in Northern California. It is affiliated with Stanford University School of Medicine, has the second-largest research enterprise in VA ($58M), trains 1500 residents, internsand students yearly and is home to every specialized Veteran treatment modality offered in the VA system. She was responsible for all administrative and clinical aspects of VA Palo Alto, including strategy and master planning for facilities. She has a Bachelor of Science degree from the University of Notre Dame in Civil Engineering and a Master of Business Administration degree from Louisiana Tech University. She is a licensed professional engineer and a Fellow in the American College of Health Care Executives. She is the recipient of two Presidential Rank Awards, one at the meritorious level and the second at the distinguished level.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

For most people, asthma is a disease you manage with inhalers, pills, and a prayer that the ER isn't your next stop. But new research is upending that view and changing everything we know about managing the condition.  The big shift? Medication alone might be the least effective way to manage this chronic condition.  Asthma is, after all, inflammatory by nature, but the lifestyle choices that fuel or fight inflammation are often ignored in traditional care plans.  What if the real triggers aren't just pollen or pets, but processed food, poor sleep, and unchecked anxiety? And what if healing asthma requires more than bronchodilators, like learning how to breathe all over again?  So what does a truly modern, whole-person approach to asthma look like?  In this episode, I'm joined by Dr. Atoosa Kourosh, an Asthma, Allergy & Immunology consultant physician and integrative medicine leader who's spent two decades treating asthma from every angle, not just the pharmaceutical one.  We dive into what the latest science says about lifestyle as medicine, and how breathwork, nutrition, exercise, and gut health are changing the game for asthma patients everywhere. Things You'll Learn In This Episode  Why your exhale matters more than your inhale Most asthma patients struggle more with getting air out than in. What do breathing techniques like Buteyko and Papworth do that traditional deep breathing doesn't, and how can they rewire the lungs for better control? Can a Mediterranean diet reduce airway inflammation? Forget calorie counting. How do whole foods, fiber, and fermented veggies change your lung health through your gut? How obesity triggers two kinds of asthma dysfunction What's the double whammy effect of body fat on asthmatic lungs? The cortisol-microbiome-asthma triangle What happens to your microbiome when you miss a night of sleep?   Guest Bio Dr. Atoosa Kourosh, MD, MPH, RYT, is a physician, board-certified in Pediatrics, Asthma, Allergy & Immunology, and Public Health. She's also a patient health advocate. Dr. Kourosh combines treatment modalities from cutting-edge and mainstream medicine with the best of functional and integrative medicine therapies and traditional philosophies to treat the whole person in their environment. She is chair of the American College of Allergy, Asthma, and Immunology Integrative Medicine Committee and is an internationally renowned expert on holistic and integrative health. Visit https://www.doctoratoosa.com/ to learn more.    About Your Host Hosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.   Resources Feeling stuck and want guidance on how to transform your spiritual, mental and physical well being? Get access to Dr Deepa's 6 Pillars of Health video! Visit drdeepa-tlc.org to subscribe and watch the video for free. ‌ Work with Me Ready to explore a personalized wellness journey with Dr. Deepa? Visit drdeepa-tlc.org and click on “Work with Me” to schedule a free intake call. Together, we'll see if this exclusive program aligns with your needs!  Want to receive a devotional every week From Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit https://www.drdeepa-tlc.org/devotional-opt-in to subscribe for free. Ready to deepen your understanding of trauma and kick start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced. Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!

What if everything we thought we knew about motivating people to exercise was wrong? In this eye-opening episode, we explore the counterintuitive science of sustainable physical activity with behavioral scientist Dr. Michelle Segar and lifestyle medicine physician Dr. Rakesh Jatwani.Here's a shocking revelation: telling patients to exercise "for their health" might actually be sabotaging their long-term motivation. Dr. Segar shares research showing that health-focused exercise messaging can be as demotivating as weight-loss goals, while Dr. Jatwani candidly admits, "I was doing harm in the way I was talking about exercise" before discovering these evidence-based approaches.Both experts take us behind the scenes of their upcoming workshop at the American College of Lifestyle Medicine conference, where they'll present a simple, practical framework for healthcare providers to transform how they discuss physical activity with patients. This framework, grounded in behavioral science yet accessible enough to deploy in time-limited clinical settings, promises to bridge the gap between good intentions and sustainable habits.Ready to transform how you think about physical activity motivation? Listen now, and discover why movement that enhances daily quality of life creates more lasting change than exercise prescribed solely for health benefits.Show Notes Page: https://www.wellnessparadoxpod.com/podcast/episode/146Our Guests: Dr. Michelle Segar, PhD & Dr. Rak Jotwani, MDDr. Michelle Segar is an award-winning, NIH-funded researcher at the University of Michigan with thirty years studying how to help people adopt physical activity and other lifestyle behaviors in ways that can be sustained within the unpredictability of the real world. Since 1994, her scientifically supported methodologies have been transforming peoples' mindsets about lifestyle behaviors in ways that cultivate the daily decision-making that underlies behavioral sustainability.Dr. Rakesh (Rak, pronounced "rock") Jotwani is a board-certified lifestyle medicine physician and the founder of RAK Your Life, a virtual practice dedicated to empowering individuals to make sustainable, evidence-based lifestyle changes. Dr. Jotwani's career has spanned hospital medicine, primary care, and leadership roles, including serving as the Director of Lifestyle Medicine at Kaiser Permanente San Francisco. Follow us on social at the links below: https://www.facebook.com/wellnessparadox https://www.instagram.com/wellnessparadox/ https://www.linkedin.com/company/wellness-paradox-podcast https://twitter.com/WellnessParadox

The Trump Administration ordered universities to turn over data to prove they're not considering race in admissions. But education expert Richard Kahlenberg argues that for college admissions to look at merit fairly, they need to look at class.

When the gallbladder turns hostile, sometimes you must do more than just pause—you have to call in a senior partner for help. Join the Behind the Knife EGS team at Mizzou as we dive into the art and grit of open cholecystectomy. From fundus-first dissection to navigating the “barrier to happiness,” this episode is packed with surgical pearls, tough love, and the kind of wisdom only scars can teach. Participants: Dr. Rushabh Dev FACS (Moderator, Surgical Attending) – Assistant Professor of Surgery, Associate PD ACS & SCCM Fellowship, SICU Medical Director, Lieutenant Commander United States Navy Reserve  Dr. Jeffery Coughenour FACS (Surgical Attending) – Professor of Surgery and Emergency Medicine, Trauma Medical Director at the University of Missouri SOM Dr. Christopher Nelson FACS (Surgical Attending) – Associate Professor of Surgery, Medical Director of Emergency General Surgery at the University of Missouri SOM Dr. Micah Ancheta (ACS Fellow) – Major, United States Airforce  Dr. Desra Fletcher (3rd year general surgery resident) Learning Objectives:  ·      Recognize Indications for Conversion Identify clinical and intraoperative factors that necessitate conversion from laparoscopic to open cholecystectomy. ·      Apply Risk Stratification Tools Utilize grading systems (e.g., Parkland, Tokyo, AAST) to assess cholecystitis severity and predict surgical difficulty. ·      Implement Safe Cholecystectomy Techniques Describe the six steps of the SAGES Safe Cholecystectomy Program to minimize bile duct injury. ·      Understand Bailout Strategies Differentiate between fenestrating and reconstituting subtotal cholecystectomy techniques and their respective risks. ·      Master Key Operative Steps Outline the essential components of open cholecystectomy: positioning, incision, exposure, and dissection. ·      Navigate High-Risk Anatomy Recognize “zones of danger” and use the B-SAFE mnemonic to reorient and ensure safe progression. ·      Develop Intraoperative Judgment Demonstrate when to proceed with subtotal techniques, convert to open, or call for assistance. ·      Perform Technical Nuances Safely Identify proper dissection planes, manage gallbladder bed inflammation, and secure cystic structures with confidence. ·      Prevent and Manage Complications Understand the risks of bile leaks, bilomas, and subcostal hernias—and how to mitigate them through technique and closure. ·      Foster Surgical Maturity Emphasize humility, collaboration, and mentorship in difficult operations—knowing when to ask for help is a skill. References: 1.     Dhanasekara, C. S., Shrestha, K., Grossman, H., Garcia, L. M., Maqbool, B., Luppens, C., ... & Dissanaike, S. (2024). A comparison of outcomes including bile duct injury of subtotal cholecystectomy versus open total cholecystectomy as bailout procedures for severe cholecystitis: A multicenter real-world study. Surgery, 176(5), 605–613. https://doi.org/10.1016/j.surg.2024.03.057 2.     Motter, S. B., de Figueiredo, S. M. P., Marcolin, P., Trindade, B. O., Brandao, G. R., & Moffett, J. M. (2024). Fenestrating vs reconstituting laparoscopic subtotal cholecystectomy: A systematic review and meta-analysis. Surgical Endoscopy, 38, 7475–7485. https://doi.org/10.1007/s00464-024-11225-8 3.     Brunt, L. M., Deziel, D. J., Telem, D. A., Strasberg, S. M., Aggarwal, R., Asbun, H., ... & Stefanidis, D. (2020). Safe cholecystectomy multi-society practice guideline and state of the art consensus conference on prevention of bile duct injury during cholecystectomy. Surgical Endoscopy.https://www.sages.org/publications/guidelines/safe-cholecystectomy-multi-society-practice-guideline/ 4.     Elshaer, M., Gravante, G., Thomas, K., Sorge, R., Al-Hamali, S., & Ebdewi, H. (2015). Subtotal cholecystectomy for “difficult gallbladders”: Systematic review and meta-analysis. JAMA Surgery, 150(2), 159–168. https://doi.org/10.1001/jamasurg.2014.1219 5.     Koo, S. S. J., Krishnan, R. J., Ishikawa, K., Matsunaga, M., Ahn, H. J., Murayama, K. M., & Kitamura, R. K. (2024). Subtotal vs total cholecystectomy for difficult gallbladders: A systematic review and meta-analysis. The American Journal of Surgery, 229(1), 145–150. https://doi.org/10.1016/j.amjsurg.2023.12.022 6.     Strasberg, S. M., Pucci, M. J., Brunt, L. M., & Deziel, D. J. (2016). Subtotal cholecystectomy—“Fenestrating” vs “reconstituting” subtypes and the prevention of bile duct injury: Definition of the optimal procedure in difficult operative conditions. Journal of the American College of Surgeons, 222(1), 89–96. https://doi.org/10.1016/j.jamcollsurg.2015.09.019 7.     Ahmed, O., & Walsh, T. N. (2020). Surgical trainee experience with open cholecystectomy and the Dunning-Kruger effect. Journal of Surgical Education.https://doi.org/10.1016/j.jsurg.2020.03.025 8.     Seshadri, A., & Peitzman, A. B. (2024). The difficult cholecystectomy: What you need to know. The Journal of Trauma and Acute Care Surgery, 97(3), 325–336. https://doi.org/10.1097/TA.0000000000004156 9.     Invited commentary on “A comparison of outcomes including bile duct injury of subtotal cholecystectomy versus open total cholecystectomy as bailout procedures for severe cholecystitis: A multicenter real-world study”. (2024). Surgery, 176(5), 614–615. https://doi.org/10.1016/j.surg.2024.05.003 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Recently, the American College of Obstetricians and Gynecologists rejected federal funding in response to the current US administration's polices. We talk about what this means.See omnystudio.com/listener for privacy information.